Channels - Analysis of Predictors of Response Degree to Omalizumab in 124 Patients with Chronic Spontaneous Urticaria :: FRELIP Discovery

Similar Items: Analysis of Predictors of Response Degree to Omalizumab in 124 Patients with Chronic Spontaneous Urticaria

Quick Look
Successful Treatment of Refractory Chronic Spontaneous Urticaria with Stapokibart After Omalizumab Failure: A Case Report
Quick Look
The Impact of Chronic Spontaneous Urticaria on Sleep—A Systematic Review
Quick Look
Review on the Application of Biologic Factors in Atopic Dermatitis and Chronic Spontaneous Urticaria
Quick Look
Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
Quick Look
Phenotypic and Dermoscopic Features in First-Degree Relatives of Melanoma Patients: A Controlled Cross-Sectional Study
Quick Look
Uncommon congenital haemangioma with focal GLUT-1 positivity and spontaneous involution: A new missing link
Quick Look
Patient Preferences for Treatment Attributes in Moderate to Severe Chronic Hand Eczema: A Discrete Choice Experiment
Quick Look
Incidence and Predictors of Opportunistic Infection Among People Living With HIV in Ethiopia: A Systematic Review and Meta-Analysis
Quick Look
The State of the Art in Chronic Prurigo Nodularis
Quick Look
Chronic Hand Eczema of Charlie Chaplin
Quick Look
Metastatic squamous cell carcinoma complicating a chronic leprosy ulcer: Highlighting the need for long-term surveillance of ‘cured’ leprosy patients
Quick Look
Chronic Pruritic Papular Eruption in an Elderly Man
Quick Look
Cutaneous Tuberculosis Presenting as a Chronic Dermatologic Disorder
Quick Look
Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study
Quick Look
HIV in Gaza: From Chronic Under‐Detection to Acute Collapse
Quick Look
Chronic refractory cutaneous sarcoidosis successfully treated with oral tofacitinib
Quick Look
Neuroimmune Genetic Overlap Between Chronic Pruritic Skin Diseases and Major Depressive Disorder: Insights from Cross-Trait GWAS Analysis
Quick Look
Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis
Quick Look
Distribution and Predictors of Skin Diseases in a Multicenter Clinic-Based Cohort Across Four Regions of India
Quick Look
Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials
Quick Look
Association Between Bimekizumab’s Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II
Quick Look
Efficacy and Safety of Sonidegib in the Treatment of Multiple Facial Cutaneous Basal Cell Carcinomas with Chronic Renal Insufficiency: A Case Report
Quick Look
A Response to: “Letter to the Editor Regarding ‘Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis’”
Quick Look
Cost–Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan